Table 1 Laboratory variables of control patients and AST-120-treated patients
From: Oral Adsorbent AST-120 Decreases Serum Levels of AGEs in Patients with Chronic Renal Failure
| Â | Control patients | AST-120-treated patients | ||
|---|---|---|---|---|
Baseline | After 3 months | Before treatment | After 3 months of treatment | |
Body weight (kg) | 57.9 ± 11.7 | 57.2 ± 12.7 | 58.3 ± 11.1 | 57.9 ±11.4 |
Fasting plasma glucose (mg/dL) | 85.2 ±6.4 | 83.8 ± 4.6 | 90.8 ± 4.0 | 89.8 ± 4.8 |
Systolic BP (mmHg) | 126 ± 21 | 136 ± 8.4 | 123 ± 16 | 125 ± 29 |
Diastolic BP (mmHg) | 68 ± 8.8 | 72 ± 11 | 74 ±9.4 | 72 ± 9.2 |
BUN (mg/dL) | 44.4 ± 18.5 | 49.1 ± 20.9 | 52.3 ± 18.3 | 49.6 ± 21.7 |
Serum creatinine (mg/dL) | 4.5 ± 2.0 | 4.9 ± 2.0 | 4.4 ±1.7 | 4.8 ± 1.9 |
Urinary protein excretion (g/day) | 2.3 ± 1.7 | 3.0 ±3.3 | 1.8 ±1.5 | 1.5 ± 1.3a |